Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia

Figure 1

Progression-free survival of patients with glioblastoma with (red line) or without (blue line) IDH1 R132H gene mutation.